HEADER HYDROLASE/HYDROLASE INHIBITOR 23-NOV-15 5EXN TITLE FACTOR XIA (C500S [C122S]) IN COMPLEX WITH THE INHIBITOR METHYL ~{N}- TITLE 2 [4-[2-[(1~{S})-1-[[(~{E})-3-[5-CHLORANYL-2-(1,2,3,4-TETRAZOL-1-YL) TITLE 3 PHENYL]PROP-2-ENOYL]AMINO]-2-PHENYL-ETHYL]PYRIDIN-4- TITLE 4 YL]PHENYL]CARBAMATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XIA LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FXI,PLASMA THROMBOPLASTIN ANTECEDENT,PTA; COMPND 5 EC: 3.4.21.27; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F11; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SMD1168H; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZALPHAA KEYWDS HYDROLASE, SERINE PROTEASE, COAGULATION FACTOR, SYNTETHIC INHIBITOR, KEYWDS 2 BLOOD, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 4 27-SEP-23 5EXN 1 HETSYN REVDAT 3 29-JUL-20 5EXN 1 COMPND JRNL REMARK HETNAM REVDAT 3 2 1 LINK SITE REVDAT 2 27-APR-16 5EXN 1 JRNL REVDAT 1 13-APR-16 5EXN 0 JRNL AUTH J.R.CORTE,T.FANG,D.J.P.PINTO,M.J.ORWAT,W.HAN,A.R.RENDINA, JRNL AUTH 2 J.M.LUETTGEN,K.A.ROSSI,A.WEI,V.RAMAMURTHY,J.E.MYERS JR., JRNL AUTH 3 S.SHERIFF,R.NARAYANAN,T.HARPER,J.J.ZHENG,Y.-X.LI, JRNL AUTH 4 D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN JRNL TITL ORALLY BIOAVAILABLE PYRIDINE AND PYRIMIDINE-BASED FACTOR XIA JRNL TITL 2 INHIBITORS: DISCOVERY OF THE METHYL N-PHENYL CARBAMATE P2 JRNL TITL 3 PRIME GROUP JRNL REF BIOORG.MED.CHEM. V. 24 2257 2016 JRNL REFN ESSN 1464-3391 JRNL PMID 27073051 JRNL DOI 10.1016/J.BMC.2016.03.062 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.L.QUAN,P.C.WONG,C.WANG,F.WOERNER,J.M.SMALLHEER, REMARK 1 AUTH 2 F.A.BARBERA,J.M.BOZARTH,R.L.BROWN,M.R.HARPEL,J.M.LUETTGEN, REMARK 1 AUTH 3 P.E.MORIN,T.PETERSON,V.RAMAMURTHY,A.R.RENDINA,K.A.ROSSI, REMARK 1 AUTH 4 C.A.WATSON,A.WEI,G.ZHANG,D.SEIFFERT,R.R.WEXLER REMARK 1 TITL TETRAHYDROQUINOLINE DERIVATIVES AS POTENT AND SELECTIVE REMARK 1 TITL 2 FACTOR XIA INHIBITORS REMARK 1 REF J.MED.CHEM. V. 57 955 2014 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.J.HANGELAND,T.J.FRIENDS,K.A.ROSSI,J.M.SMALLHEER,C.WANG, REMARK 1 AUTH 2 Z.SUN,J.R.CORTE,T.FANG,P.C.WONG,A.R.RENDINA,F.A.BARBERA, REMARK 1 AUTH 3 J.M.BOZARTH,J.M.LUETTGEN,C.A.WATSON,G.ZHANG,A.WEI, REMARK 1 AUTH 4 V.RAMAMURTHY,P.E.MORIN,G.S.BISACCHI,S.SUBRAMANIAM, REMARK 1 AUTH 5 P.ARUNACHALAM,A.MATHUR,D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN REMARK 1 TITL PHENYLIMIDAZOLES AS POTENT AND SELECTIVE INHIBITORS OF REMARK 1 TITL 2 COAGULATION FACTOR XIA WITH IN VIVO ANTITHROMBOTIC ACTIVITY REMARK 1 REF J.MED.CHEM. V. 57 9915 2014 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.R.CORTE,T.FANG,J.J.HANGELAND,T.J.FRIENDS,A.R.RENDINA, REMARK 1 AUTH 2 J.M.LUETTGEN,J.M.BOZARTH,F.A.BARBERA,K.A.ROSSI,A.WEI, REMARK 1 AUTH 3 V.RAMAMURTHY,P.E.MORIN,D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN REMARK 1 TITL PYRIDINE AND PYRIDINONE-BASED FACTOR XIA INHIBITORS REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 25 925 2015 REMARK 1 REFN ISSN 0960-894X REMARK 1 REFERENCE 4 REMARK 1 AUTH D.J.P.PINTO,J.M.SMALLHEER,J.R.CORTE,E.J.D.AUSTIN,C.WANG, REMARK 1 AUTH 2 T.FANG,L.M.SMITH II,K.A.ROSSI,A.R.RENDINA,J.M.BOZARTH, REMARK 1 AUTH 3 G.ZHANG,A.WEI,V.RAMAMURTHY,S.SHERIFF,J.E.MYERS JR., REMARK 1 AUTH 4 P.E.MORIN,J.M.LUETTGEN,D.A.SEIFFERT,M.L.QUAN,R.R.WEXLER REMARK 1 TITL STRUCTURE-BASED DESIGN OF INHIBITORS OF COAGULATION FACTOR REMARK 1 TITL 2 XIA WITH NOVEL P1 MOIETIES REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 25 1635 2015 REMARK 1 REFN ISSN 0960-894X REMARK 1 REFERENCE 5 REMARK 1 AUTH Z.HU,P.C.WONG,P.J.GILLIGAN,W.HAN,K.B.PABBISETTY,J.M.BOZARTH, REMARK 1 AUTH 2 E.J.CRAIN,T.HARPER,J.M.LUETTGEN,J.E.MYERS JR.,V.RAMAMURTHY, REMARK 1 AUTH 3 K.A.ROSSI,S.SHERIFF,C.A.WATSON,A.WEI,J.J.ZHENG,D.A.SEIFFERT, REMARK 1 AUTH 4 R.R.WEXLER,M.L.QUAN REMARK 1 TITL DISCOVERY OF A POTENT PARENTERALLY ADMINISTERED FACTOR XIA REMARK 1 TITL 2 INHIBITOR WITH HYDROXYQUINOLIN-2(1H)-ONE AS THE P2' MOIETY REMARK 1 REF A.C.S.MED.CHEM.LETT. V. 6 590 2015 REMARK 1 REFN ISSN 1948-5875 REMARK 1 REFERENCE 6 REMARK 1 AUTH L.M.SMITH II,M.J.ORWAT,Z.HU,W.HAN,C.WANG,K.A.ROSSI, REMARK 1 AUTH 2 P.J.GILLIGAN,K.B.PABBISETTY,H.OSUNA,J.R.CORTE,A.R.RENDINA, REMARK 1 AUTH 3 J.M.LUETTGEN,P.C.WONG,R.NARAYANAN,T.HARPER,J.M.BOZARTH, REMARK 1 AUTH 4 E.J.CRAIN,A.WEI,V.RAMAMURTHY,P.E.MORIN,D.A.SEIFFERT, REMARK 1 AUTH 5 M.L.QUAN,P.Y.S.LAM,R.R.WEXLER,D.J.P.PINTO REMARK 1 TITL NOVEL PHENYLALANINE DERIVED DIAMIDES AS FACTOR XIA REMARK 1 TITL 2 INHIBITORS REMARK 1 REF BIOORG.MED.CHEM.LETT. 2015 REMARK 1 REFN ESSN 1464-3405 REMARK 1 DOI 10.1016/J.BMCL.2015.11.089 REMARK 2 REMARK 2 RESOLUTION. 1.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 38331 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.760 REMARK 3 FREE R VALUE TEST SET COUNT : 1823 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2929 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1969 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2779 REMARK 3 BIN R VALUE (WORKING SET) : 0.1962 REMARK 3 BIN FREE R VALUE : 0.2109 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1851 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.35960 REMARK 3 B22 (A**2) : -0.06170 REMARK 3 B33 (A**2) : 3.42130 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.154 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.071 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.071 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.068 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.068 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.957 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2004 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2749 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 683 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 40 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 349 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2004 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 259 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : 2 ; 1.000 ; HARMONIC REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2460 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.29 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.11 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EXN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215667. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : KIRKPARTICK-BAEZ REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38508 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.490 REMARK 200 RESOLUTION RANGE LOW (A) : 42.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.37400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3SOR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE, PH 5.0, REMARK 280 36%(W/V) PEG4000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.44500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.66000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.56000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.66000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.44500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.56000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 245 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 61 CG CD OE1 OE2 REMARK 470 LYS A 64 CE NZ REMARK 470 GLU A 78 CG CD OE1 OE2 REMARK 470 ASP A 79 CG OD1 OD2 REMARK 470 LYS A 126 CD CE NZ REMARK 470 ASP A 128 CG OD1 OD2 REMARK 470 ARG A 129 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 130 CG OD1 ND2 REMARK 470 ILE A 132 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 50 29.47 -140.40 REMARK 500 LYS A 95 -52.33 -126.89 REMARK 500 ASP A 128 43.64 -97.80 REMARK 500 ASP A 149 -150.16 -154.31 REMARK 500 SER A 214 -65.58 -122.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5EXL RELATED DB: PDB REMARK 900 RELATED ID: 5EXM RELATED DB: PDB DBREF 5EXN A 16 245 UNP P03951 FA11_HUMAN 388 625 SEQADV 5EXN SER A 122 UNP P03951 CYS 500 ENGINEERED MUTATION SEQRES 1 A 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 A 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 A 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 A 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 A 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER SEQRES 6 A 238 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 A 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 A 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN SEQRES 9 A 238 TYR THR ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS SEQRES 10 A 238 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 A 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 A 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 A 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 A 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 A 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 A 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 A 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 A 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 A 238 THR GLN ALA VAL HET NAG A 301 14 HET 5SU A 302 68 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 5SU METHYL ~{N}-[4-[2-[(1~{S})-1-[[(~{E})-3-[5-CHLORANYL-2- HETNAM 2 5SU (1,2,3,4-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL]AMINO]-2- HETNAM 3 5SU PHENYL-ETHYL]PYRIDIN-4-YL]PHENYL]CARBAMATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 5SU C31 H26 CL N7 O3 FORMUL 4 HOH *221(H2 O) HELIX 1 AA1 ALA A 55 TYR A 58B 5 6 HELIX 2 AA2 SER A 62 LYS A 64 5 3 HELIX 3 AA3 ASN A 72 ILE A 76 5 5 HELIX 4 AA4 MET A 96 GLY A 100 5 5 HELIX 5 AA5 THR A 164 TYR A 171 1 9 HELIX 6 AA6 TYR A 234 GLN A 243 1 10 SHEET 1 AA1 8 THR A 20 ALA A 21 0 SHEET 2 AA1 8 GLN A 156 LYS A 159 -1 O LYS A 157 N THR A 20 SHEET 3 AA1 8 CYS A 136 GLY A 140 -1 N GLY A 140 O GLN A 156 SHEET 4 AA1 8 PRO A 198 HIS A 203 -1 O SER A 200 N TRP A 137 SHEET 5 AA1 8 VAL A 206 TRP A 215 -1 O VAL A 206 N HIS A 203 SHEET 6 AA1 8 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 AA1 8 MET A 180 ALA A 183 -1 N ILE A 181 O TYR A 228 SHEET 8 AA1 8 LEU A 162 VAL A 163 -1 N VAL A 163 O CYS A 182 SHEET 1 AA2 7 GLN A 30 THR A 35 0 SHEET 2 AA2 7 ARG A 39 GLY A 48 -1 O LEU A 41 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 4 AA2 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 AA2 7 PHE A 83 ILE A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 AA2 7 LEU A 65A TYR A 67 -1 N VAL A 66 O PHE A 83 SHEET 7 AA2 7 GLN A 30 THR A 35 -1 N HIS A 34 O ARG A 65B SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.01 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.06 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.02 LINK ND2 ASN A 113 C1 NAG A 301 1555 1555 1.43 CISPEP 1 SER A 36A PRO A 36B 0 -2.59 CRYST1 38.890 69.120 85.320 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025714 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011721 0.00000